F.P. Report
PESHAWAR: As many as 13,000 diabetic patients of various districts of the province have benefited from “Insulin for Life Project” in Khyber Pakhtunkhwa and health department Khyber Pakhtunkha has planned to extend it for three-years to ensure free healthcare to patients in the province.
As per details issued by information department of Khyber Pakhtunkhwa, the project was initiated in 2014 by health department and currently 16 centres in 12 districts of the province have been established. It further clarified that registered patients have been receiving insulin free of cost in these centres.
Project Director, Insulin for Life Project, Doctor AH Amir said that health department was mulling over extension of the project for another three years and PC-1 of the project has been prepared in this regard.
“We have increased the number of covered districts from 12 to 15 and the department plans to extend the initiative to the entire province. The registration and provision of medicine to diabetic patients is made through a computerised process” he claimed.
The project is now planned to be initiated in 15 districts of KP including Peshawar, Mardan, Charsada, Nowshera, Chitral, Swat, Abbottabad, Lower Dir, Upper Dir, Haripur, Bannu, DI Khan, Kohat, and Lakki Marwat.
Dr Amir added that the provision of free insulin to type-1 and type-2 diabetic patients have reduced various ailments related to eyes, kidneys and cardiac problems commonly found in diabetic patients.
He further said that 5087 patients have been saved from amputations alone. Moreover, 2882 patients with kidney and 2882 diabetic patients with heart diseases have been helped in avoiding complexities.
The extension of the project for the next three years is not only focused towards provision of free insulin to registered patients but will also include awareness campaigns in which public would be sensitized about diabetes and other related diseases and threats in case the disease is not properly treated. Moreover, diabetic patients would be provided with cholesterol control medicines and capacity building trainings and workshops will be organised for doctors of the designated districts.
